SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Daina, Antoine ^a   Michielin, Olivier ^a,b,c   Zoete, Vincent ^a  

^a SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMISTRY; DRUG DEVELOPMENT; MOLECULAR LIBRARY; PHARMACOKINETICS; PHARMACOLOGY; PROCEDURES; SOFTWARE;

DRUG DISCOVERY; SMALL MOLECULE LIBRARIES; SOFTWARE;

EID: 85014610206     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42717     Document Type: Article

References (77)

1. Hay, M., Tomas, D. W., Craighead, J. L., Economides, C. & Rosenthal, J. Clinical development success rates for investigational drugs. Nature Biotechnol. 32, 40-51 (2014).
2. Dahlin, J. L., Inglese, J. & Walters, M. A. Mitigating risk in academic preclinical drug discovery. Nature Rev. Drug Discov. 14, 279-294 (2015).
3. Tian, S. et al. The application of in silico drug-likeness predictions in pharmaceutical research. Adv Drug Deliv Rev 86, 2-10 (2015).
4. Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev. 46, 3-26 (2001).
5. Brenk, R. et al. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem 3, 435-444 (2008).
6. Baell, J. B. & Holloway, G. A. New substructure flters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem. 53, 2719-2740 (2010).
7. Bruns, R. F. & Watson, I. A. Rules for Identifying Potentially Reactive or Promiscuous Compounds. J. Med. Chem. 55, 9763-9772 (2012).
8. Irwin, J. J. et al. An Aggregation Advisor for Ligand Discovery. J. Med. Chem. 58, 7076-7087 (2015).
9. O'Boyle, N. M. et al. OpenBabel: An open chemical toolbox. J. Cheminform. 3, 33 (2011).
10. Cereto-Massaguà, A. et al. Molecular fngerprint similarity search in virtual screening. Methods 71, 58-63 (2015).
11. Ertl, P. & Schufenhauer, A. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J. Cheminform. 1, 8 (2009).
12. Clark, A. M. et al. Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets. J. Chem. Inf. Model. 55, 1231-1245 (2015).
13. Mitchell, J. B. O. Machine learning methods in chemoinformatics. WIREs Comput. Mol. Sci. 4, 468-481 (2014).
14. Pires, D. E. V., Blundell, T. L. & Ascher, D. B. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J. Med. Chem. 58, 4066-4072 (2015).
15. Cheng, F. et al. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J. Chem. Inf. Model. 52, 3099-3105 (2012).
16. Daina, A., Michielin, O. & Zoete, V. iLOGP: A Simple, Robust, and Efcient Description of n-Octanol/Water Partition Coefcient for Drug Design Using the GB/SA Approach. J. Chem. Inf. Model. 54, 3284-3301 (2014).
17. Daina, A. & Zoete, V. A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules. ChemMedChem 11, 1117-1121 (2016).
18. Zoete, V., Daina, A., Bovigny, C. & Michielin, O. SwissSimilarity: A Web Tool for Low to Ultra High Troughput Ligand-Based Virtual Screening. J. Chem. Inf. Model. 56, 1399-1404 (2016).
19. Gfeller, D. et al. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 42, W32-W38 (2014).
20. Grosdidier, A., Zoete, V. & Michielin, O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 39, W270-7 (2011).
21. Wirth, M., Zoete, V., Michielin, O. & Sauer, W. H. B. SwissBioisostere: a database of molecular replacements for ligand design. Nucleic Acids Res. 41, D1137-43 (2013).
22. Zoete, V., Cuendet, M. A., Grosdidier, A. & Michielin, O. SwissParam: a fast force feld generation tool for small organic molecules. J. Comput. Chem. 32, 2359-2368 (2011).
23. Ritchie, T. J., Ertl, P. & Lewis, R. The graphical representation of ADME-related molecule properties for medicinal chemists. Drug Discov. Today 16, 65-72 (2011).
24. Lovering, F., Bikker, J. & Humblet, C. Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success. J. Med. Chem. 52, 6752-6756 (2009).
25. Ertl, P., Rohde, B. & Selzer, P. Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties. J. Med. Chem. 43, 3714-3717 (2000).
26. Pliska, V., Testa, B. & van de Waterbeemd, H. In Lipophilicity in Drug Action and Toxicology 1-6 (Wiley-VCH Verlag GmbH, 1996).
27. Arnott, J. A. & Planey, S. L. The Influence of lipophilicity in drug discovery and design. Expert Opin. Drug Discov. 7, 863-875 (2012).
28. Mannhold, R., Poda, G. I. & Ostermann, C. Calculation of molecular lipophilicity: State-of-the-art and comparison of log P methods on more than 96, 000 compounds. J. Pharm. Sci. 98, 861-893 (2009).
29. Cheng, T. et al. Computation of Octanol-Water Partition Coefcients by Guiding an Additive Model with Knowledge. J Chem Inf Model 47, 2140-2148 (2007).
30. Wildman, S. A. & Crippen, G. M. Prediction of Physicochemical Parameters by Atomic Contributions. J. Chem. Inf. Model. 39, 868-873 (1999).
31. Moriguchi, I., Shuichi, H., Liu, Q., Nakagome, I. & Matsushita, Y. Simple Method of Calculating Octanol/Water Partition Coefcient. Chem. Pharm. Bull. 40, 127-130 (1992).
32. Moriguchi, I., Shuichi, H., Nakagome, I. & Hirano, H. Comparison of reliability of log P values for Drugs calculated by several methods. Chem. Pharm. Bull. 42, 976-978 (1994).
33. Ritchie, T. J., Macdonald, S. J. F., Peace, S., Pickett, S. D. & Luscombe, C. N. Increasing small molecule drug developability in sub-optimal chemical space. Med. Chem. Commun. 4, 673 (2013).
34. Ottaviani, G. et al. What is modulating solubility in simulated intestinal fuids? Eur J Pharm Sci 41, 452-457 (2010).
35. Savjani, K. T., Gajjar, A. K. & Savjani, J. K. Drug solubility: importance and enhancement techniques. ISRN Pharm 2012, 195727 (2012).
36. Delaney, J. S. ESOL: Estimating Aqueous Solubility Directly from Molecular Structure. J. Chem. Inf. Model. 44, 1000-1005 (2004).
37. Ali, J., Camilleri, P., Brown, M. B., Hutt, A. J. & Kirton, S. B. Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area. J. Chem. Inf. Model. 52, 420-428 (2012).
38. Yalkowsky, S. H. & Valvani, S. C. Solubility and partitioning I: Solubility of nonelectrolytes in water. J Pharm Sci 69, 912-922 (1980).
39. Potts, R. O. & Guy, R. H. Predicting Skin Permeability. Pharm. Res. 09, 663-669 (1992).
40. Montanari, F. & Ecker, G. F. Prediction of drug-ABC-transporter interaction-Recent advances and future challenges. Adv. Drug Deliv. Rev. 86, 17-26 (2015).
41. Szakács, G., Váradi, A., Ozvegy-Laczka, C. & Sarkadi, B. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov. Today 13, 379-393 (2008).
42. Sharom, F. J. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9, 105-127 (2008).
43. Testa, B. & Kraemer, S. D. The Biochemistry of Drug Metabolism-An Introduction-Testa-2007-Chemistry & Biodiversity-Wiley Online Library. Chem. Biodivers (2007).
44. van Waterschoot, R. A. B. & Schinkel, A. H. A critical analysis of the interplay between cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic mice. Pharmacological Reviews 63, 390-410 (2011).
45. Wolf, C. R., Smith, G. & Smith, R. L. Pharmacogenetics. British Medical Journal (2000).
46. Di, L. The role of drug metabolizing enzymes in clearance. Expert Opin. Drug Metab. Toxicol. 10, 379-393 (2014).
47. Hollenberg, P. F. Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metab. Rev. 34, 17-35 (2002).
48. Huang, S.-M. et al. New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J. Clin. Pharmacol. 48, 662-670 (2008).
49. Kirchmair, J. et al. Predicting drug metabolism: experiment and/or computation? Nature Rev. Drug Discov. 14, 387-404 (2015).
50. Veith, H. et al. Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries. Nature Biotechnol. 27, 1050-1055 (2009).
51. Cortes, C. & Vapnik, V. Support-vector networks. Mach. Learn. 20, 273-297 (1995).
52. Mishra, N. K., Agarwal, S. & Raghava, G. P. Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule. BMC Pharmacol. 10, 8 (2010).
53. Sedykh, A. et al. Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm. Res. 30, 996-1007 (2015).
54. Rostkowski, M., Spjuth, O. & Rydberg, P. WhichCyp: prediction of cytochromes P450 inhibition. Bioinformatics 29, 2051-2052 (2013).
55. Sun, H., Veith, H., Xia, M., Austin, C. P. & Huang, R. Predictive models for cytochrome p450 isozymes based on quantitative high throughput screening data. J. Chem. inf. Model. 51, 2474-2481 (2011).
56. Carbon-Mangels, M. & Hutter, M. C. Selecting Relevant Descriptors for Classifcation by Bayesian Estimates: A Comparison with Decision Trees and Support Vector Machines Approaches for Disparate Data Sets. Mol. Inf. 30, 885-895 (2011).
57. Wang, Z. et al. P-glycoprotein substrate models using support vector machines based on a comprehensive data set. J. Chem. Inf. Model. 51, 1447-1456 (2011).
58. Ghose, A. K., Viswanadhan, V. N. & Wendoloski, J. J. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb. Chem. 1, 55-68 (1999).
59. Veber, D. F. et al. Molecular properties that Influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615-2623 (2002).
60. Egan, W. J., Merz, K. M. & Baldwin, J. J. Prediction of Drug Absorption Using Multivariate Statistics. J. Med. Chem. 43, 3867-3877 (2000).
61. Muegge, I., Heald, S. L. & Brittelli, D. Simple selection criteria for drug-like chemical matter. J. Med. Chem. 44, 1841-1846 (2001).
62. Martin, Y. C. A Bioavailability Score. J. Med. Chem. 48, 3164-3170 (2005).
63. Hann, M. M. & Keseru, G. M. Finding the sweet spot: the role of nature and nurture in medicinal chemistry. Nature Rev. Drug Discov. 11, 355-365 (2012).
64. Teague, S., Davis, A., Leeson, P. & Oprea, T. The Design of Leadlike Combinatorial Libraries. Angew. Chem. Int. Ed. Engl. 38, 3743-3748 (1999).
65. Fukunishi, Y., Kurosawa, T., Mikami, Y. & Nakamura, H. Prediction of synthetic accessibility based on commercially available compound databases. J Chem Inf Model 54, 3259-3267 (2014).
66. Zoete, V., Daina, A., Bovigny, C. & Michielin, O. SwissSimilarity. A web tool for low to ultra high-throughput ligand-based virtual screening. J. Chem. Inf. Model. 58, 1399-1404 (2016).
67. Gfeller, D., Michielin, O. & Zoete, V. SwissSidechain: a molecular and structural database of non-natural sidechains. Nucleic Acids Res. 41, D327-32 (2013).
68. Lee, M. S., Feig, M., Salsbury, F. R. & Brooks, C. L. New analytic approximation to the standard molecular volume defnition and its application to generalized Born calculations. J. Comput. Chem. 24, 1348-1356 (2003).
69. Brooks, B. R. et al. CHARMM: the biomolecular simulation program. J. Comput. Chem. 30, 1545-1614 (2009).
70. Mak, L. et al. Metrabase: a cheminformatics and bioinformatics database for small molecule transporter data analysis and (Q)SAR modeling. J. Cheminform. 7, 31 (2015).
71. Poongavanam, V. V., Haider, N. N. & Ecker, G. F. G. Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors. Bioorg. Med. Chem. 20, 5388-5395 (2012).
72. Kim, S. et al. PubChem Substance and Compound databases. Nucleic Acids Res. 44, D1202-13 (2016).
73. Ward, J. H. Jr. Hierarchical Grouping to Optimize an Objective Function. Journal of the American Statistical Association (1963).
74. Chang, C.-C. & Lin, C.-J. LIBSVM. ACM Trans. Intell. Syst. Technol. 2, 1-27 (2011).
75. Egan, W. J. & Lauri, G. Prediction of intestinal permeability. Adv. Drug Deliv. Rev. 54, 273-289 (2002).
76. Irwin, J. J. & Shoichet, B. K. ZINC-A free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 45, 177-182 (2005).
77. Cheng, F. et al. Classifcation of Cytochrome P450 Inhibitors and Noninhibitors Using Combined Classifers. J. Chem. Inf. Model. 51, 996-1011 (2011).